Total Payments
$7,145
2024 Payments
$845.59
Companies
47
Transactions
379
Medicare Patients
2,549
Medicare Billing
$451,107
Payment Breakdown by Category
Food & Beverage$7,124 (99.7%)
Education$21.00 (0.3%)
Gifts$0.01 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,124 | 377 | 99.7% |
| Education | $21.00 | 1 | 0.3% |
| Gift | $0.01 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,002 | 43 | $0 (2023) |
| Nevro Corp. | $688.78 | 28 | $0 (2023) |
| Daiichi Sankyo Inc. | $673.50 | 43 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $540.72 | 32 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $485.84 | 25 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $484.51 | 36 | $0 (2024) |
| SI-BONE, Inc. | $475.84 | 10 | $0 (2022) |
| PFIZER INC. | $208.68 | 13 | $0 (2019) |
| Purdue Pharma L.P. | $191.18 | 14 | $0 (2018) |
| Valinor Pharma, LLC | $181.95 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $845.59 | 53 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($333.30) |
| 2023 | $708.08 | 22 | Zynex Medical, Inc. ($176.46) |
| 2022 | $819.28 | 31 | SI-BONE, Inc. ($244.16) |
| 2020 | $221.45 | 13 | Abbott Laboratories ($87.82) |
| 2019 | $1,434 | 80 | Nevro Corp. ($471.94) |
| 2018 | $1,702 | 112 | Daiichi Sankyo Inc. ($337.04) |
| 2017 | $1,415 | 68 | Abbott Laboratories ($553.08) |
All Payment Transactions
379 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Gastroenterology | ||||||
| 12/30/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: PSYCHIATRY | ||||||
| 11/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Opioid Analgesic | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: Gastroenterology | ||||||
| 10/28/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: PSYCHIATRY | ||||||
| 10/06/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| Category: Opioid Analgesic | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Gastroenterology | ||||||
| 09/06/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Gastroenterology | ||||||
| 08/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Opioid Analgesic | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Gastroenterology | ||||||
| 08/19/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $24.91 | General |
| 07/29/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 785 | 1,940 | $901,259 | $136,042 |
| 2022 | 9 | 314 | 881 | $638,211 | $99,198 |
| 2021 | 2 | 84 | 132 | $78,146 | $12,232 |
| 2020 | 28 | 1,366 | 3,526 | $1.1M | $203,635 |
Total Patients
2,549
Total Services
6,479
Medicare Billing
$451,107
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 123 | 588 | $274,008 | $39,732 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 383 | $251,332 | $30,884 | 12.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 112 | $102,959 | $14,837 | 14.4% |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 2023 | 95 | 162 | $24,300 | $10,589 | 43.6% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 95 | 220 | $51,480 | $7,422 | 14.4% |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | Office | 2023 | 95 | 220 | $45,760 | $6,793 | 14.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $36,480 | $4,431 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $27,616 | $4,133 | 15.0% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 32 | $14,560 | $3,391 | 23.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 11 | 17 | $15,572 | $3,374 | 21.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 14 | 17 | $14,484 | $2,448 | 16.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 44 | $9,108 | $2,043 | 22.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 11 | 13 | $12,844 | $1,978 | 15.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 15 | 26 | $8,814 | $1,518 | 17.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 11 | 14 | $6,622 | $1,403 | 21.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 28 | $5,320 | $1,065 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 593 | $391,079 | $57,611 | 14.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 134 | $122,028 | $20,356 | 16.7% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 30 | 30 | $42,480 | $6,964 | 16.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $28,500 | $4,128 | 14.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 11 | 18 | $16,488 | $3,488 | 21.2% |
| 99358 | Extended patient service without direct patient contact, first hour | Office | 2022 | 31 | 31 | $17,577 | $2,846 | 16.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 11 | 18 | $8,514 | $1,703 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 19 | $8,854 | $1,415 | 16.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 13 | 13 | $2,691 | $686.53 | 25.5% |
About Dr. John Beelitz, M.D
Dr. John Beelitz, M.D is a Interventional Pain Medicine healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2013. The National Provider Identifier (NPI) number assigned to this provider is 1003249566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Beelitz, M.D has received a total of $7,145 in payments from pharmaceutical and medical device companies, with $845.59 received in 2024. These payments were reported across 379 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($7,124).
As a Medicare-enrolled provider, Beelitz has provided services to 2,549 Medicare beneficiaries, totaling 6,479 services with total Medicare billing of $451,107. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Pain Medicine
- Location Palm Beach Gardens, FL
- Active Since 08/19/2013
- Last Updated 01/21/2026
- Taxonomy Code 208VP0014X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003249566
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $628.91
- Morphabond ER (Drug) $605.11
- SCS IPGs (Device) $439.35
- RELISTOR (Drug) $421.71
- Proclaim Family of SCS IPGs (Device) $355.79
- MOVANTIK (Drug) $326.74
- XTAMPZA (Drug) $261.60
- iFuse Implant (Device) $231.68
- ZTLido (Drug) $221.67
- LYRICA (Drug) $194.28
- mild Device Kit (Device) $180.37
- Nexwave (Device) $176.46
- RELISTOR ORAL (Drug) $153.48
- DRG IPGs (Device) $129.82
- Horizant (Drug) $125.45
- BUNAVAIL 2.1 mg 30-count box (Drug) $114.61
- SPRIX (Drug) $102.42
- CAPLYTA (Drug) $100.52
- Belbuca (Drug) $98.41
- Movantik (Drug) $93.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.